Introducing ALAN Inc.'s Ventures and Challenges | Startup League (LEAGUE MEMBER)

ALAN Inc. 's News & Column
NEW INFORMATION

2025/11/18

STARTUP LEAGUE

"Improving Snoring With a Game" Is No Longer a Dream: A Keio-Born Startup Challenges the Paradigm of SAS Treatment

In recent years, many people have likely heard the term "Sleep Apnea Syndrome" (SAS). It is a disease in which apnea (a state where breathing stops for 10 seconds or more) occurs 5 or more times per hour during sleep, or is repeated 30 or more times over a 7-hour night.

ALAN Inc.'s Main Innovation
INNOVATION

Development of an Application to Improve Symptoms of Sleep Apnea

We aim to commercialize a therapeutic smartphone app that analyzes apnea indices measured by our proprietary home sleep assessment device, nemurin®, using cloud-based analysis and AI to guide patients toward improvement within two weeks. nemurin?'s medical-grade measurement and analysis algorithms (patent pending) and its clinical trial framework centered on sleep clinics create high entry barriers, which are expected to improve treatment continuation rates and promote early screening for the estimated 9 million potential patients, thereby reducing medical costs. As research and development elements, the company is focusing on: ① developing a smartphone app, ② developing an AI algorithm that proposes optimized intervention plans for each patient, and ③ creating educational content to promote understanding of the condition. Ultimately, these elements will be integrated into a unified system.

Spread the Word

Share on X Share on Facebook

ALAN Inc. Representative Introduction
REPRESENTATIVE

Representative	Takahiro Kondo After graduating from St. Marianna University School of Medicine in 2009, he earned a PhD in medicine from Keio University Graduate School. After working for five years as a special assistant professor in medical-engineering collaboration research, he became an assistant professor at Keio University School of Medicine in 2019. He has led numerous research projects on neuroscience and rehabilitation as a project leader. With the aim of applying research findings and skills to society, he founded ALAN Co., Ltd. in February 2021. He has published 15 research papers and co-authored the book “Medicine × Business” (Medica Publishing), which will be published in 2024. Currently, he serves as the director of a sleep clinic, a visiting assistant professor at Keio University School of Medicine, and a board member of the Japan Health Management Specialist Association.

Representative

Takahiro Kondo
After graduating from St. Marianna University School of Medicine in 2009, he earned a PhD in medicine from Keio University Graduate School. After working for five years as a special assistant professor in medical-engineering collaboration research, he became an assistant professor at Keio University School of Medicine in 2019. He has led numerous research projects on neuroscience and rehabilitation as a project leader. With the aim of applying research findings and skills to society, he founded ALAN Co., Ltd. in February 2021. He has published 15 research papers and co-authored the book “Medicine × Business” (Medica Publishing), which will be published in 2024. Currently, he serves as the director of a sleep clinic, a visiting assistant professor at Keio University School of Medicine, and a board member of the Japan Health Management Specialist Association.

ALAN Inc. Basic Informaton
BASIC
INFORMATION

Company Name	ALAN Inc.
Representative Name	Takahiro Kondo
Address	1-8-10 Motohashi, Sakae-ku, Yokohama-shi, Kanagawa-ken
Official Site and Social Media	Official Website
Founding Date	February 2021

ALAN Inc. 's News & Column NEW INFORMATION

ALAN Inc.'s Main Innovation INNOVATION